MedTrace Logo

Combined Therapy With L-Thyroxine and L-Triiodothyronine Compared to L-Thyroxine Alone

NCT00715572 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2008-07-15

No results posted yet for this study

Summary

The objective of this study was to analyze the features of monotherapy with L-T4 in comparison with combined therapy with L-T4 and L-T3 in patients with primary hypothyroidism.

Conditions

Interventions

DRUG

thyroxine

monotherapy with thyroxine

DRUG

thyroxine and triiodothyronine

combination with thyroxine and triiodothyronine

Sponsors & Collaborators

  • I.M. Sechenov First Moscow State Medical University

    lead OTHER

Principal Investigators

  • Valentin V Fadeyev · Moscow Medical Academy, Department of Endocrinology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
48 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-03-31
Primary Completion
2004-02-29
Completion
2004-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00715572 on ClinicalTrials.gov